Doyle Anthony insider trades
Doyle Anthony has filed 10 Form 4s with the SEC that we hold, all for Biocryst Pharmaceuticals INC (BCRX), as Chief Financial Officer. Across all of them we count 2 purchases worth $642.2K and 1 sale worth $62.1K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 35,258 shares of Biocryst Pharmaceuticals INC worth $440.0K, dated 2021-11-23. The first filing on our record is dated 2021-11-24 and the latest 2024-12-23.
Biocryst Pharmaceuticals INC (BCRX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-11-23 | P, purchase reported on Form 4 | 35,258 | $440.0K | 2021-11-24 |
| 2022-12-15 | S, sale reported on Form 4 | 5,700 | $62.1K | 2022-12-19 |
| 2024-05-14 | P, purchase reported on Form 4 | 36,300 | $202.2K | 2024-05-15 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1808688) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms